NRG-BR008/HERO study: a Phase III randomized trial of radiotherapy optimization for low-risk HER2-positive breast cancer
NRG-BR008/HERO 研究:一项针对低危 HER2 阳性乳腺癌的放射治疗优化 III 期随机试验
期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2511586
Braunstein, Lior Z; Mitchell, Melissa P; Bandos, Hanna; Sikov, William M; Khan, Atif J; Chen, Peter Y; Ganz, Patricia A; Jagsi, Reshma; White, Julia R; Cecchini, Reena S; Kang, Hyejoo; Puhalla, Shannon L; Bolton, Kelly L; Connolly, Eileen P; Stringer-Reasor, Erica M; Gergelis, Kimberly R; Julian, Thomas B; Mamounas, Eleftherios P; Wolmark, Norman